Senior insider sale
President and CEO at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$291.4K
29.17K shares
What this filing means
CAMPBELL BRADLEY L plans to sell 29.17K shares of AMICUS THERAPEUTICS, INC. valued at approximately $291.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001950047-25-009525
DirectorOfficer· President and CEO
Since Mar 2026
29.17K
Shares to sell
$291.4K
Approx. market value
14.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/1/2025
14.59KTotal acquired14.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/1/2025 | Exercise of Stock Options Cash | 14.59K | — |
| Total | 14.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
14.59K
Market value
$146.5K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.59K
Market value
$144.8K
12/1/2025
Total
Units
29.17K
Value
$291.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/24/2025 | 14.59K | $146.5K | — | Completed |
| Planned — Approximate Date | ||||
12/1/2025 | 14.59K | $144.8K | NASDAQ | Planned |
| Total | 29.17K | $291.4K | ||